Holen Sie sich die Stockscreener-App
1.53
1.92%
-0.03
Handel nachbörslich:
1.49
-0.04
-2.61%
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewswire Inc.
Is the Market Bullish or Bearish on MAIA Biotechnology Inc? - Benzinga
MAIA Biotechnology Completes $30 Million Public Stock Offering - TipRanks
Maia Biotechnology Inc enters underwriting agreement with Konik Capital PartnersSEC filing - marketscreener.com
Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital PartnersSEC Filing - TradingView
MAIA Biotechnology Prices $30 Million Offering of 20 Million Shares at $1.50 - TradingView
MAIA Biotechnology (NYSE American: MAIA) closes $30M common stock raise - Stock Titan
Cancer drug developer MAIA raises $30M to fund new trials - Stock Titan
[424B5] MAIA Biotechnology, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
MAIA Shares Fall After Pricing of $30 Million Public Offering - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
MAIA Biotechnology shares drop 29% on discounted stock offering By Investing.com - Investing.com Canada
Cancer immunotherapy firm MAIA raises $30M for trials, costs - Stock Titan
MAIA Biotechnology Prices $30 Mln Public Offering Of Shares At $1.50/shr; Stock Down - Nasdaq
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - ChartMill
MAIA Biotechnology (NYSE: MAIA) offers common stock and pre-funded warrants - Stock Titan
Cancer immunotherapy developer MAIA plans stock sale to fund trials - Stock Titan
MAIA Should I Buy - Intellectia AI
MAIAMAIA Biotechnology Inc. Latest Stock News & Market Updates - Stock Titan
MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program - TipRanks
MAIA Biotechnology cites Phase 3 momentum for ateganosine, targets $50B immunotherapy market - TradingView
MAIA Biotechnology (NYSE: MAIA) touts Phase 3 NSCLC drug and Fast Track - Stock Titan
MAIA Biotechnology : Shareholder Letter - marketscreener.com
MAIA Biotechnology’s Phase 3 Momentum Demonstrates - GlobeNewswire
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market - 富途牛牛
Portfolio Update: Can MAIA Biotechnology Inc grow without dilutionJuly 2025 Earnings & Weekly High Potential Stock Alerts - baoquankhu1.vn
MAIA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MACD Signal: How does Franklin Wireless Corp perform in inflationary periodsPortfolio Value Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Quarterly Recap: What is the next catalyst for MAIA Biotechnology IncGlobal Markets & Accurate Buy Signal Alerts - baoquankhu1.vn
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Sees Significant Growth in Short Interest - MarketBeat
Whale Trades: How do insiders feel about MAIA Biotechnology IncWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Weekly Recap: What is the next catalyst for MAIA Biotechnology IncMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars - MSN
Why MAIA Biotechnology Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Stepwise Trade Execution Plans - mfd.ru
MAIA Technical Analysis & Stock Price Forecast - Intellectia AI
Does MAIA Biotechnology Inc. have pricing power2025 Performance Recap & Low Risk High Win Rate Picks - mfd.ru
What’s the MACD signal for MAIA Biotechnology Inc.2025 Macro Impact & Low Risk High Win Rate Stock Picks - mfd.ru
Is MAIA Biotechnology Inc. showing insider buying2025 EndofYear Setup & Weekly High Return Forecasts - mfd.ru
Is MAIA Biotechnology Inc. stock showing strong momentumGDP Growth & Real-Time Sentiment Analysis - mfd.ru
What are the future prospects of MAIA Biotechnology IncSwing Trade & Daily Technical Forecast Reports - baoquankhu1.vn
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.5%Should You Buy? - MarketBeat
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.5% – Should You Buy? - Defense World
Why MAIA Biotechnology Inc. stock is popular among millennialsPortfolio Value Summary & Daily Growth Stock Investment Tips - mfd.ru
Fed Watch: Will MAIA Biotechnology Inc outperform small cap indexes2025 Market Sentiment & Safe Investment Capital Preservation Plans - baoquankhu1.vn
MAIA Biotechnology announces significant insider buying - MSN
Risk Analysis: Is Roblox Corporation stock risky to hold now2025 Year in Review & High Accuracy Investment Signals - baoquankhu1.vn
$207B Market Shift: The Race for Fast Track Approval in Oncology (2026-02-05) - Seeking Alpha
$207B Market Shift: The Race for Fast Track Approval in Oncology - Sahm
Geopolitics Watch: What are the future prospects of MAIA Biotechnology IncTrade Analysis Summary & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment - The Globe and Mail
Late-Stage Breakthroughs: How 2026’s Top Clinical Platforms Are Redefining Cancer Treatment - Cantech Letter
Growth Value: Is MAIA Biotechnology Inc stock forming a cup and handleJuly 2025 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
Aug Highlights: What is MAIA Biotechnology Incs TAM Total Addressable Market2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Buyback Watch: Is Milestone Pharmaceuticals Inc undervalued by DCF analysis2025 Volume Leaders & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Tech Rally: What are the future prospects of MAIA Biotechnology Inc2025 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
MAIA 's Outlines 2026 Milestones On Ateganosine In Cancer Treatment Program; Stock Down - Nasdaq
MAIA Biotechnology outlines 2026 goals for ateganosine program - TipRanks
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program - TradingView — Track All Markets
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum - The Manila Times
MAIA Biotechnology Advances Ateganosine Cancer Treatment - GlobeNewswire
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4% – Time to Buy? - Defense World
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4%Time to Buy? - MarketBeat
Trend Report: Should I buy BOSC stock nowJuly 2025 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
MAIA Biotechnology (MAIA) Price Target Decreased by 15.37% to 10.48 - Nasdaq
MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks
3.69%
0.68%
Kapitalisierung:
|
Volumen (24h):